IBI322
innovent biologics
['hodgkin', 'lymphoma', 'innovent']
innovent presents p-i clinical trial results of ibi322 for the treatment of classic hodgkin lymphoma at eha 2023 
Real-time summarized News in 3 shots from pharma, biotech, medtech, digital health and life sciences industry readable in 60 seconds